TY - JOUR T1 - Maternal depressive symptoms, neonatal white matter, and toddler social-emotional development JF - medRxiv DO - 10.1101/2022.04.28.22274095 SP - 2022.04.28.22274095 AU - Alexandra Lautarescu AU - Alexandra F. Bonthrone AU - Maximilian Pietsch AU - Dafnis Batalle AU - Lucilio Cordero-Grande AU - J-Donald Tournier AU - Daan Christiaens AU - Joseph V Hajnal AU - Andrew Chew AU - Shona Falconer AU - Chiara Nosarti AU - Suresh Victor AU - Michael C. Craig AU - A. David Edwards AU - Serena J. Counsell Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/04/29/2022.04.28.22274095.abstract N2 - Maternal prenatal depression is associated with increased likelihood of neurodevelopmental and psychiatric conditions in offspring. The relationship between maternal depression and offspring outcome may be mediated by in-utero changes in brain development. Recent advances in magnetic resonance imaging (MRI) have enabled in vivo investigations of neonatal brains, minimising the effect of postnatal influences. The aim of this study was to examine associations between maternal prenatal depressive symptoms, infant white matter, and toddler behaviour. 413 mother-infant dyads enrolled in the developing Human Connectome Project. Mothers completed the Edinburgh Postnatal Depression Scale (median = 5, range = 0-28, n=52 scores ≥ 11). Infants (n=223 male) (median gestational age at birth=40 weeks, range 32.14-42.29) underwent MRI (median postmenstrual age at scan=41.29 weeks, range 36.57-44.71). Fixel-based fibre metrics (mean fibre density, fibre cross- section, and fibre density modulated by cross-section) were calculated from diffusion imaging data in the left and right uncinate fasciculi and cingulum bundle. For n=311, internalizing and externalizing behaviour, and social-emotional abilities were reported at a median corrected age of 18 months (range 17-24). Statistical analysis used multiple linear regression and mediation analysis with bootstrapping. Maternal depressive symptoms were positively associated with infant fibre density in the left (B =.0005, p=.003, q=.027) and right (B=.0006, p=.003, q=.027) uncinate fasciculus, with the left uncinate fasciculus, in turn, positively associated with social-emotional abilities in toddlerhood (B =105.70, p=.0007, q=.004). In a mediation analysis, higher maternal depressive symptoms predicted toddler social-emotional difficulties (B=.342, t(307)=3.003, p=.003), but this relationship was not mediated by fibre density in the left uncinate fasciculus (Sobel test p=.143, bootstrapped indirect effect=.035, SE=.02, 95%CI [-.01,.08]). There was no evidence of an association between maternal depressive and cingulum fibre properties. These findings suggest that maternal perinatal depressive symptoms are associated with neonatal uncinate fasciculi microstructure, but not fibre bundle size, and toddler behaviour.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received funding from the European Research Council under the European Union Seventh Framework Programme (FP7/20072013/ECR grant agreement no [319456] dHCP project) and the Medical Research Council [grant numbers MR/N013700 and MR/V002465/1]. This paper represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centres at South London and Maudsley NHS Foundation Trust and at MRC Centre for Neurodevelopmental Disorders at Kings College London. This work was supported by core funding from the Wellcome/EPSRC Centre for Medical Engineering [WT203148/Z/16/Z]. DC is supported by a post-doctoral fellowship of the Flemish Research Foundation (FWO) [12ZV420N]. DB received support from a Wellcome Trust Seed Award in Science [217316/Z/19/Z].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the UK National Research Ethics Authority (London - Riverside 14/LO/1169) and conducted in accordance with the World Medical Association Code of Ethics (Declaration of Helsinki).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesImaging data and minimal demographics data are available online at http://www.developingconnectome.org/data-release/. We are unable to share further data as this would increase the risk of participant identification. ER -